A Latin American syndemic?
Mixing the words ‘synergy’ with ‘epidemic,’ a syndemic occurs when multiple points of suffering, including health ailments as well as socio-economic inequities, unite to create a combined and worsened effect on the health of a population. Syndemic thinking helps understand how tropical diseases spread and even coinfect the discriminated, stigmatized, and poverty-stricken social groups living in Latin America’s slums. In the case of Malaria, for instance, over a third of the region’s cases are located in Venezuela, a country which continues to endure the worst economic recession in Latin America and is one of the nations with the lowest share of its gross domestic product spent on health.The syndemic quality of tropical diseases in Latin America can be best observed when looking at Brazil. The South American nation has by far the most infections of chikungunya, dengue, and Zika in the region, and is simultaneously considered one of Latin America’s most unequal countries based on wealth distribution. In addition, these tropical diseases are most common in the same, heavily populated areas of Brazil. The state of Bahia, for example, is among the top four states with the most probable dengue cases.
A vexing vaccine
Two vaccines do exist for dengue. However, the only vaccine available up until recently is rather controversial because it can increase the risk of severe infection for some patients who have not been previously infected with the tropical disease. It is therefore important for people to know, and be able to prove, any prior dengue infections. As the value of the global dengue testing market continues to grow throughout the following years, better, and increased testing can assist patients in getting proper care against this tropical disease. However controversial the first ever developed vaccine for dengue may be, the value of the global virus’ vaccine market is worth billions of U.S. dollars and is expected to grow over the following five years. This allows us to look forward to safer solutions to dengue and similar, deadly tropical diseases. A new vaccine also apt for people who have not previously been infected by the virus has already been approved in places like Indonesia and the European Union.
